Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Correlation Between Grade of Ovarian and Endometrial Carcinoma and the Expression of PD-1/PDL-1.

NCT04528940 is registered in ClinicalTrials.gov with RWJ Barnabas Health at Jersey City Medical Center as lead sponsor.

NCT NCT04528940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Correlation Between Grade of Ovarian and Endometrial Carcinoma and the Expression of PD-1/PDL-1.
Lead sponsor
RWJ Barnabas Health at Jersey City Medical Center
Phase
Observational
Overall status
Unknown status
Start date
August 25, 2020
Completion date
September 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, ovarian cancer